NCT02094885View on ClinicalTrials.gov

The Bioseal Vascular Study

PHASE4CompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

February 1, 2014

Primary Completion Date

November 1, 2014

Study Completion Date

December 1, 2014

Conditions
Cardiovascular BleedingVascular BleedingHemorrhage
Interventions
BIOLOGICAL

Bioseal Fibrin Sealant

OTHER

Manual Compression

Trial Locations (9)

100029

Clinical Investigation Site #26, Beijing

100853

Clinical Investigation Site #28, Beijing

200032

Clinical Investigation Site #23, Shanghai

210008

Clinical Investigation Site #32, Nanjing

210029

Clinical Investigation Site #31, Nanjing

250021

Clinical Investigation Site #30, Jinan

510080

Clinical Investigation Site #21, Guangzhou

610041

Clinical Investigation Site #22, Chengdu

2000011

Clinical Investigation Site #25, Shanghai

All Listed Sponsors
collaborator

Guangzhou Bioseal Biotechnology Co., Ltd.

INDUSTRY

lead

Ethicon, Inc.

INDUSTRY

NCT02094885 - The Bioseal Vascular Study | Biotech Hunter | Biotech Hunter